These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8148801)

  • 1. Relationship between the tissue distribution and antitumor activity of highly branched (1-->3)-beta-D-glucan, SSG.
    Suda M; Ohno N; Adachi Y; Yadomae T
    Biol Pharm Bull; 1994 Jan; 17(1):131-5. PubMed ID: 8148801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue distribution of intraperitoneally administered (1-->3)-beta-D-glucan (SSG), a highly branched antitumor glucan, in mice.
    Suda M; Ohno N; Adachi Y; Yadomae T
    J Pharmacobiodyn; 1992 Aug; 15(8):417-26. PubMed ID: 1479542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
    Ohno N; Kurachi K; Yadomae T
    J Pharmacobiodyn; 1987 Sep; 10(9):478-86. PubMed ID: 3437391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the antitumor effect and tissue distribution of highly branched (1-->3)-beta-D-glucan, SSG, by carrageenan.
    Suda M; Ohno N; Adachi Y; Yadomae T
    Biol Pharm Bull; 1995 May; 18(5):772-5. PubMed ID: 7492998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intraperitoneally administered beta-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the functions of murine alveolar macrophages.
    Sakurai T; Suzuki I; Kinoshita A; Oikawa S; Masuda A; Ohsawa M; Yadomae T
    Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):214-7. PubMed ID: 2049804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a highly branched beta-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the growth of syngeneic tumors in mice.
    Suzuki I; Hashimoto K; Yadomae T
    J Pharmacobiodyn; 1988 Aug; 11(8):527-32. PubMed ID: 3236210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and antitumor activity of hydroxyethylated derivatives of 6-branched (1----3)-beta-D-glucan, SSG, obtained from the culture filtrate of Sclerotinia sclerotiorum IFO 9395.
    Kurachi K; Ohno N; Yadomae T
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2527-31. PubMed ID: 2285987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of soluble fungal (1-->3)-beta-D-glucan obtained from Sclerotinia sclerotiorum on alveolar macrophage activation.
    Sakurai T; Ohno N; Suzuki I; Yadomae T
    Immunopharmacology; 1995 Aug; 30(2):157-66. PubMed ID: 8530257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of hematopoietic response of mice by intraperitoneal administration of a beta-glucan, SSG, obtained from Sclerotinia sclerotiorum.
    Hashimoto K; Suzuki I; Ohsawa M; Oikawa S; Yadomae T
    J Pharmacobiodyn; 1990 Aug; 13(8):512-7. PubMed ID: 2079647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of beta-D-glucan from edible mushroom after injection into mouse peritoneal cavity.
    Sone Y; Shibata S; Kishida E; Misaki A
    J Nutr Sci Vitaminol (Tokyo); 1994 Aug; 40(4):335-41. PubMed ID: 7844640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic 13C-labeling of an antitumor (1-->3)-beta-D-glucan, SSG, from Sclerotinia sclerotiorum IFO 9395.
    Suda M; Ohno N; Adachi Y; Yadomae T
    Biosci Biotechnol Biochem; 1995 Feb; 59(2):203-7. PubMed ID: 7766018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and properties of metabolically 3H- or 13C-labeled (1-->3)-beta-D-glucan, SSG, from Sclerotinia sclerotiorum IFO 9395.
    Suda M; Ohno N; Adachi Y; Yadomae T
    Carbohydr Res; 1994 Feb; 254():213-9. PubMed ID: 8180985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of grifolan NMF-5N (I/B), a chemically modified antitumor beta-glucan in mice.
    Takeyama T; Suzuki I; Ohno N; Oikawa S; Sato K; Ohsawa M; Yadomae T
    J Pharmacobiodyn; 1988 Jun; 11(6):381-5. PubMed ID: 3171879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kupffer cells play important roles in the metabolic degradation of a soluble anti-tumor (1-->3)-beta-D-glucan, SSG, in mice.
    Suda M; Ohno N; Hashimoto T; Koizumi K; Adachi Y; Yadomae T
    FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):93-100. PubMed ID: 8880133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different role of serum components and cytokines on alveolar macrophage activation by soluble fungal (1-->3)-beta-D-glucan.
    Sakurai T; Kaise T; Yadomae T; Matsubara C
    Eur J Pharmacol; 1997 Sep; 334(2-3):255-63. PubMed ID: 9369356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation by orally administered beta-glucan in mice.
    Suzuki I; Hashimoto K; Ohno N; Tanaka H; Yadomae T
    Int J Immunopharmacol; 1989; 11(7):761-9. PubMed ID: 2599714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenously administered (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 augments murine peritoneal macrophage functions in vivo.
    Sakurai T; Ohno N; Yadomae T
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2120-4. PubMed ID: 1423766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of (1-->3)-beta-D-glucan in mice.
    Miura T; Ohno N; Suda M; Miura NN; Shimada S; Yadomae T
    Biol Pharm Bull; 1995 Dec; 18(12):1797-1801. PubMed ID: 8787813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood clearance of (1-->3)-beta-D-glucan in MRL lpr/lpr mice.
    Miura NN; Ohno N; Aketagawa J; Tamura H; Tanaka S; Yadomae T
    FEMS Immunol Med Microbiol; 1996 Jan; 13(1):51-57. PubMed ID: 8821398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of murine alveolar macrophage functions by orally administered beta-glucan.
    Sakurai T; Hashimoto K; Suzuki I; Ohno N; Oikawa S; Masuda A; Yadomae T
    Int J Immunopharmacol; 1992 Jul; 14(5):821-30. PubMed ID: 1512075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.